First Horizon Advisors’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

First Horizon Advisors’s Portfolio CDMO Stock Details CDMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-224	Closed	-$4.2K	–	2544
2023 Q1	$4.2K	Sell	224 -108	-33%	-$1.77K	﹤0.01%	1863
2022 Q4	$4.57K	Hold	332	–	–	﹤0.01%	1815
2022 Q3	$6K	Buy	332 +1	+0.3%	+$18	﹤0.01%	1733
2022 Q2	$5K	Sell	331 -204	-38%	-$3.02K	﹤0.01%	1862
2022 Q1	$11K	Buy	535 +1	+0.2%	+$20	﹤0.01%	1088
2021 Q4	$16K	Buy	+534	New	+$15.3K	﹤0.01%	1370

Other funds holding CDMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

First Horizon Advisors's CDMO Position: Q2 2023 in Review

First Horizon Advisors sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q2 2023, closing a stake of 224 shares — an estimated $4.2K sold.

First Horizon Advisors first reported a position in CDMO in Q4 2021 and held it in 6 quarters. The position peaked at $16K in Q4 2021. 169 funds tracked by Wall St. Rank hold CDMO as of Q2 2023.

First Horizon Advisors reported no remaining Avid Bioservices, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
First Horizon Advisors sold 224 Avid Bioservices, Inc. Common Stock shares in Q2 2023, an estimated $4.2K.
First Horizon Advisors first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2021 and held it in 6 quarters.
First Horizon Advisors's Avid Bioservices, Inc. Common Stock position peaked at $16K in Q4 2021.
169 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q2 2023.

Based on First Horizon Advisors's 13F filing for Q2 2023, filed 3 Aug 2023.